Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDB6F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,459
Award facts
- Contract value 100% obligated
- $21,459.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $21,459 delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 26, 2026, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 27, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies and medications to federal agencies, particularly the Department of Defense and Veterans Affairs. The parent company Cencora holds the primary $999,999,999 IDC with DLA through December 2031, while the subsidiary maintains its own $999,999,999 contract vehicle through December 2026. These arrangements enable the company to supply an extensive range of pharmaceutical products, vaccines, specialty medications, and medical supplies to support military treatment facilities and federal healthcare systems globally, demonstrating its capability to meet competitive federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FDB6F?
SPE2DR26FDB6F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FDB6F worth?
The government has obligated $21,459 on SPE2DR26FDB6F.
Is contract SPE2DR26FDB6F an order under another contract?
Yes. SPE2DR26FDB6F is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDB6F competed?
The extent of competition for SPE2DR26FDB6F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award